AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7588177
Drug: Long term
RxNorm normalized name: BENZETHONIUM CHLORIDE 0.12 g in 100 mL TOPICAL SOLUTION [CA-REZZ - LONG TERM CARE - INCONTINENT CLEANSER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long term antidepressants (in dysthymias and personality disorders)
Trial: 7588177
Drug: Long term
RxNorm normalized name: BENZETHONIUM CHLORIDE 0.12 g in 100 mL TOPICAL SOLUTION [CA-REZZ - LONG TERM CARE - INCONTINENT CLEANSER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long term antidepressant treatment
Trial: 2012292
Drug: Patient-controlled epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled epidural analgesia with higher infusion rate
Trial: 2012292
Drug: Patient-controlled epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled epidural analgesia with lower infusion rate
Trial: 7044724
Drug: Oral preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral preoperative antibiotics and systemic peroperative antibiotics
Trial: 7044724
Drug: Oral preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral preoperative antibiotics
Trial: 7044724
Drug: Systemic peroperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic peroperative antibiotics
Trial: 29961920
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human EPO (rhEPO) administered acutely to healthy humans.
Trial: 29961920
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human EPO (rhEPO) administered acutely to mice.
Trial: 29961920
Drug: Acute injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute injections of recombinant FGF23.
Trial: 23299013
Drug: Quadrivalent HPV-6/11/16/18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV-6/11/16/18 vaccine
Trial: 22209292
Drug: Monovalent HPV-16
RxNorm normalized name: HPV 16 E7/HSP65 vaccine
DrugBank: Verpasep caltespen (DB04959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent HPV-16 vaccine
Trial: 17201904
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal patches with behavioural support
Trial: 17201904
Drug: Placebo transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo transdermal patches with behavioural support
Trial: 10612536
Drug: Cytokine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine treatment (placebo-controlled)
Trial: 30398862
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro assessment of melanin binding properties of small molecules
Trial: 27317305
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of peramivir 150 mg
Trial: 27317305
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of peramivir 300 mg
Trial: 27317305
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of peramivir 600 mg
Trial: 27317305
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose of peramivir 600 mg
Trial: 20384415
Drug: Sequential name‐face
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential name‐face matching task with famous faces
Trial: 20384415
Drug: Sequential name‐face
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential name‐face matching task with nonfamous faces
Trial: 20384415
Drug: Sequential face-name
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential face-name matching task with names
Trial: 12005458
Drug: Late enteral
RxNorm normalized name: Soy protein isolate enteral formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late enteral feeding (started on day 5, with 20% of estimated daily requirements during the first 4 days)
Trial: 10424513
Drug: IV levofloxacin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV levofloxacin, 500 mg qd for 7 days
Trial: 10424513
Drug: IV alatrofloxacin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV alatrofloxacin, 200 mg qd for 7 days
Trial: 2207399
Drug: Chloroquine 25
RxNorm normalized name: chloroquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 25 mg/kg over three days
Trial: 2207399
Drug: Pyrimethamine 75
RxNorm normalized name: Pyrimethamine
DrugBank: Pyrimethamine (DB00205)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyrimethamine 75 mg and sulfadoxine 1500 mg as a single dose
Trial: 2207399
Drug: Chlorproguanil 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorproguanil 1.2 mg/kg and dapsone 2.4 mg/kg as a single dose
Trial: 30633917
Drug: Regular vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular vaginal assessments (4-hourly prior to each oral misoprostol dose)
Trial: 23504383
Drug: adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: adalimumab 40 mg every other week for 24 weeks
Trial: 19546510
Drug: Excimer laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excimer laser treatment
Trial: 15247354
Drug: Doxorubicin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin alone (30 mg/m² every three weeks for 10 doses)
Trial: 15247354
Drug: Dexrazoxane (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexrazoxane (300 mg/m²) followed by doxorubicin
Trial: 11770708
Drug: Low-dose pravastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose pravastatin (5 mg/day)
Trial: 11770708
Drug: Standard-dose pravastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose pravastatin (10-20 mg/day)
Trial: 11830951
Drug: Low level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low level laser therapy applied during and following third molar removal
Trial: 11830951
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active additional laser treatment (placebo)
Trial: 23886027
Drug: N-Acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-Acetylcysteine (NAC) 1200 mg/day + risperidone
Trial: 16800986
Drug: Kanlijian (KLJ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kanlijian (KLJ) combined with conventional therapy
Trial: 31928920
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) granules based on syndrome differentiation (Bao‐fei Hua‐xian granule, Jin‐shui Huan‐xian granule, Yang‐qing Kang‐xian granule)
Trial: 29051138
Drug: Physiotherapist-guided Ambulant
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapist-guided Ambulant Activity Feedback (AAF) therapy (n=62)
Trial: 29051138
Drug: Psychologist-guided Web-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychologist-guided Web-based mindfulness-based cognitive therapy (eMBCT; n=55)
Trial: 22728693
Drug: Single MRI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single MRI slice 5-10 cm above L(4)-L(5)
Trial: 22728693
Drug: Single MRI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single MRI slice L(4)-L(5)
Trial: 17561998
Drug: Vehicle instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle instillation (100 ml of 10% ethanol in saline)
Trial: 17561998
Drug: RTX instillation
RxNorm normalized name: RTX
DrugBank: Resiniferatoxin (DB06515)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTX instillation (100 ml of 50 nM RTX in 10% ethanol in saline)
Trial: 15447895
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) supplementation (3.0 g/d; 50:50 blend of cis-9,trans-11 CLA and trans-10,cis-12 CLA)
Trial: 9742535
Drug: Penile block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penile block plus diclofenac suppository (Group 2)
Trial: 9742535
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository alone (Group 3)
Trial: 1089363
Drug: L-tryptophan alone
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-tryptophan alone
Trial: 1089363
Drug: L-tryptophan combined
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-tryptophan combined with L-dopa
Trial: 1089363
Drug: L-dopa combined
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-dopa combined with L-tryptophan
Trial: 28488449
Drug: Individualized medication
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized medication training (20 min)
Trial: 28488449
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment without training
Trial: 19692788
Drug: Virtual reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality therapy (30 mins per session, in addition to conventional therapy)
Trial: 19692788
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (40 mins a day, 4 days a week for 4 weeks)
Trial: 15015820
Drug: Euphyllin Retard
RxNorm normalized name: diclofenac sodium Extended Release Oral Tablet [Lofensaid Retard]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euphyllin Retard 350 mg under fasting condition
Trial: 15015820
Drug: Euphyllin Retard
RxNorm normalized name: diclofenac sodium Extended Release Oral Tablet [Lofensaid Retard]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euphyllin Retard 350 mg with breakfast
Trial: 11168211
Drug: Astra-Tech (A)
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Astra-Tech (A) system - self-tapping TiO2-blasted screw-shaped implants made of commercially pure titanium
Trial: 11168211
Drug: Brånemark (B)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brånemark (B) system - self-tapping Mark II implants with machined surface irregularities
Trial: 7069070
Drug: Oral breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral breathing
Trial: 9504133
Drug: Oral breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral breathing at 60 W
Trial: 8439713
Drug: Xylocaine/proliferant injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylocaine/proliferant injections
Trial: 8439713
Drug: Xylocaine/saline solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylocaine/saline solution injections
Trial: 19846796
Drug: Closed-loop intraperitoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-loop intraperitoneal insulin infusion
Trial: 29804377
Drug: ETV monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETV monotherapy
Trial: 20305865
Drug: Systemic metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic metronidazole plus amoxicillin (AP+AB)
Trial: 20305865
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing with placebo tablets (CP)
Trial: 18534556
Drug: N-acetyl cysteine
RxNorm normalized name: N-Acetyl Cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl cysteine (NAC) 1 g twice daily adjunctive to usual medication
Trial: 12074271
Drug: Aprindine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprindine (40 mg/day)
Trial: 8125424
Drug: Digoxin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (0.25 mg/day)
Trial: 29525822
Drug: Ticagrelor (180-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (180-mg loading dose, 90 mg twice daily thereafter)
Trial: 30898608
Drug: Clopidogrel (300-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300- to 600-mg loading dose, 75 mg daily thereafter)
Trial: 21613575
Drug: Quercetin (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (2,000 mg/day)
Trial: 9420539
Drug: Wax-carbon-laser treatment
RxNorm normalized name: Candelilla Wax
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wax-carbon-laser treatment
Trial: 9420539
Drug: Wax-laser treatment
RxNorm normalized name: Candelilla Wax
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wax-laser treatment
Trial: 30144985
Drug: Placebo (mock
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (mock laser therapy)
Trial: 12795770
Drug: Alefacept 15
RxNorm normalized name: alefacept 15 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alefacept 15 mg IM
Trial: 12795770
Drug: Alefacept 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alefacept 10 mg IM
Trial: 1871078
Drug: Nurse-assisted combination
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-assisted combination intervention
Trial: 6137857
Drug: Zopiclone 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 10 mg
Trial: 30957654
Drug: Labeling condition
RxNorm normalized name: lobeline
DrugBank: Lobeline (DB05137)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labeling condition (e.g., 'sex offenders', 'murderers')
Trial: 30957654
Drug: Neutral condition
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral condition (e.g., 'people who have committed crimes of a sexual nature')
Trial: 30452511
Drug: Topical tazarotene
RxNorm normalized name: tazarotene Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tazarotene gel, 0.1%, applied once every night for 3 months.
Trial: 30452511
Drug: Microneedling therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microneedling therapy with a dermaroller (1.5 mm needle length) for a total of 4 sessions over 3 months.
Trial: 24848975
Drug: PRGF (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRGF (one dose)
Trial: 24848975
Drug: PRGF (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRGF (two doses)
Trial: 24848975
Drug: PRGF plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRGF plus HA (two doses)
Trial: 21734512
Drug: 20-hour manualized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-hour manualized group cognitive behavior therapy program
Trial: 19521894
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid 16.7 mg
Trial: 19521894
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid up to 50.1 mg
Trial: 19521894
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid (all doses)
Trial: 9150621
Drug: BMS 180048
RxNorm normalized name: BMS dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BMS 180048 150 mg
Trial: 9150621
Drug: BMS 180048
RxNorm normalized name: BMS dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BMS 180048 200 mg
Trial: 8122735
Drug: General anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthesia and postoperative intravenous morphine infusion (GA)
Trial: 2442559
Drug: lisinopril 5
RxNorm normalized name: lisinopril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisinopril 5 mg/day
Trial: 2442559
Drug: captopril 37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: captopril 37.5 mg/day
Trial: 29410934
Drug: Flexible-dose lurasidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible-dose lurasidone (40 to 160mg/d)
Trial: 29410934
Drug: Flexible-dose quetiapine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible-dose quetiapine XR (200 to 800mg/d)
Trial: 21346065
Drug: Hesperidin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hesperidin (500 mg once daily for 3 weeks)
Trial: 18564150
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (50 or 100 mg, as needed)
Trial: 14703887
Drug: Heater probe
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heater probe thermocoagulation plus hypertonic saline‐epinephrine injection
Trial: 9873176
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg twice daily)
Trial: 1313682
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (0.3 mg/kg daily) plus flucytosine (150 mg/kg daily)
Trial: 31204320
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (No preparation)
Trial: 26967937
Drug: Subthalamic nucleus
RxNorm normalized name: Sus scrofa thalamus lateral geniculate nucleus preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subthalamic nucleus deep brain stimulation (STN‐DBS) + optimal drug therapy (ODT)
Trial: 26306000
Drug: Optimal drug
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal drug therapy (ODT)
Trial: 25267694
Drug: Heart rate
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heart rate at 80 bpm and tidal volume at 6 mL/kg
Trial: 25267694
Drug: Heart rate
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heart rate at 110 bpm and tidal volume at 6 mL/kg
Trial: 25267694
Drug: Heart rate
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heart rate at 80 bpm and tidal volume at 10 mL/kg
Trial: 25267694
Drug: Heart rate
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heart rate at 110 bpm and tidal volume at 10 mL/kg
Trial: 25267694
Drug: Increasing tidal
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing tidal volume from 6 mL/kg to 10 mL/kg
Trial: 27181367
Drug: Oral Appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Appliance (OA) therapy
Trial: 15754377
Drug: Budesonide 6
RxNorm normalized name: budesonide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 6 mg/d and UDCA 15 mg/kg/d
Trial: 15754377
Drug: UDCA 15
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 15 mg/kg/d
Trial: 10549401
Drug: Allopurinol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (300 mg daily for 4 weeks)
Trial: 2505187
Drug: L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (2 g/day) for 6 weeks
Trial: 2457403
Drug: Bumetanide 1
RxNorm normalized name: bumetanide 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide 1 mg
Trial: 1277709
Drug: Bumetanide 1
RxNorm normalized name: bumetanide 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide 1 mg and Furosemide 40 mg
Trial: 30699846
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 3 g/day
Trial: 21199271
Drug: Low-dosage sulphonylurea
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dosage sulphonylurea (1-mg glimepiride; Amaryl)
Trial: 7890255
Drug: Outpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient treatment group with incomplete response
Trial: 23806096
Drug: Simultaneous infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous infusion of GLP-1 and Vitamin C
Trial: 21360201
Drug: Ice slurry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice slurry ingestion (1.25 g kg(‐1), -1°C)